SCHEMBL8087526

SCHEMBL8087526

COc1ccc(-c2nc(OC)c(C#N)cc2-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.51
CA2 P00918 5/20 0.50
CA9 Q16790 5/20 0.50
CA12 O43570 4/20 0.50
CNR2 P34972 1/20 0.50
KDM4E B2RXH2 3/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
KMT2A Q03164 1/20 0.47
POLB P06746 1/20 0.45
MAPKAPK2 P49137 1/20 0.45
PTGS2 P35354 5/20 0.44
PTGS1 P23219 2/20 0.44
CA1 P00915 4/20 0.42
CA7 P43166 1/20 0.42
CA14 Q9ULX7 1/20 0.42
IKBKB O14920 1/20 0.42
CHUK O15111 1/20 0.42
ADORA1 P30542 1/20 0.42
SQOR Q9Y6N5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8094021 0.91 KDM4E (0.47) CNR1CA2CA9CA12CNR2
SCHEMBL8087245 0.91 KDM4E (0.51) CNR1CA2CA9CA12KDM4E
SCHEMBL8100868 0.91 CA2 (0.51) CNR1CA2CA9CA12CNR2
SCHEMBL8099377 0.91 KDM4E (0.56) CNR1CA2CA9CA12CNR2
SCHEMBL8095836 0.91 KDM4E (0.45) CNR1CA2CA9CA12CNR2
SCHEMBL8092791 0.90 PTGS2 (0.47) CNR1CA2CA9CA12CNR2
SCHEMBL8093195 0.90 PTGS2 (0.47) CNR1CA2CA9CA12CNR2
SCHEMBL8093184 0.90 CNR1 (0.52) CNR1CA2CA9CA12CNR2
SCHEMBL8093748 0.89 KDM4E (0.43) CNR1CA2CA9CA12CNR2
SCHEMBL8095681 0.89 CA2 (0.51) CNR1CA2CA9CA12CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP claimed
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed